Introduction
At least 85% of individuals with multiple sclerosis (MS) report gait disturbance as their primary complaint (Kelleher et al. 2010) . The most common measure of walking in MS clinical trials is the Expanded Disability Status Scale (EDSS). The EDSS is the gold standard of MSrelated disability; however, ambulation score for the EDSS is based on distance and assistance level without regard for elements such as time to complete walking, quality of walking, or ability to adapt walking to meet functional demands. Issues with reliability (Amato et al., 1988; Koziol et al,. 1996) , responsiveness (Hobart et al., 2000) , and other limitations (Avasarala, 2015; MeyerMoock et al., 2015) of the EDSS have also been well-documented. Although valid, its use in clinical trials for tracking disease progression is based primarily on international acceptability (Meyer-Moock et al., 2015) and has been criticized for both high variability and because the non-linearity of the scale makes determination of change challenging (Amato and Ponziani, 1999; Hyland and Rudick, 2011) . Quantitative measures of walking and strength impairment address the weaknesses of the EDSS (Zackowski et al., 2015) and may improve disease monitoring.
Tract-specific white-matter imaging, such as diffusion tensor imaging (DTI) and magnetization transfer (MT) imaging are not typically part of conventional magnetic resonance imaging (MRI) for monitoring disease progression. However, these techniques allow for quantification of individualized differences. DTI quantifies the directional diffusivity of water and provides information about the integrity of white matter tracts in the brain, while MT quantifies the degree of magnetization transfer among free water protons and protons bound to macromolecules, as occurs in lipids such as in myelin in the white matter. The primary outcome measure for DTI is fractional anisotropy (FA), a scalar value between 0 (isotropic diffusion) and 1 (anisotropic diffusion) (Jones, 2009) ; the primary outcome measure for MT is the magnetization transfer ratio (MTR), which is significantly correlated with myelin content in individuals with MS (Schmierer et al., 2004 
In contrast to conventional MRI, these tract-specific techniques allow for quantification of the heterogeneity among individuals, and may ultimately lead to individualized treatments and rehabilitation.
Previous work using DTI and MT has focused on relationships among strength (Reich et al., 2008; Zackowski et al., 2009; Oh et al., 2013a) and walking (Zackowski et al., 2009; Naismith et al., 2013) with spinal cord imaging, particularly the lateral columns, which are assumed to be more closely related to the corticospinal tract (CST) in MS. Lower extremity strength is significantly related to MTR of the lateral columns (Zackowski et al., 2009 ) and FA of the whole cord (Oh et al., 2013a) ; while brainstem CST MTR dissociates stronger from weaker muscle strength (Reich et al., 2008) . Walking performance has been associated with DTI (Naismith et al., 2013) and MTR (Zackowski et al., 2009 ) of the lateral columns in MS. T25FW
performance (Tovar-Moll et al., 2015; Klineova et al., 2016; Hubbard et al., 2016) and walking velocity and endurance (Hubbard et al., 2016) were related to DTI measures, while both total EDSS and Functional Systems Score (FSS) pyramidal scores were related to FA of the brain CST measured from the pons to the cortex (Tovar-Moll et al., 2015) , and total EDSS score was also correlated with cervical spinal cord area (Bernitsas et al., 2015) . However, controls were not included in these studies, and relationships of quantitative measures of strength and walking to brain MTR have not been explored, and DTI of the whole-brain CST from medulla to cortex in relation to function is lacking in MS.
The use of more objective functional measures (i.e., strength and walking), as well as tract-specific imaging methods may improve our ability to monitor disease change over time, with intervention, and provide needed guidelines for developing more effective targeted rehabilitation strategies. Exploration of whole brain CST measures may be important for the development of sensitive outcome measures. Outcome measurement for MS clinical trials has been challenging (Hyland and Rudick, 2011) . Though imaging outcomes are used to guide diagnosis and medical management in MS, the relationships among imaging variables and clinical measures remains unclear. We hypothesized that quantitative walking and strength measures would be related to brain CST-specific measures, and would provide insight into the heterogeneity of brain pathology. Therefore, the objectives of this study were to explore the relationship of clinical measures of walking and strength to whole brain CST-specific MRI measures and to determine the contribution of quantitative measures of function in addition to (Newsome et al., 2011) . Hip flexion, extension and abduction were collected using the methods previously described by our laboratory (Keller et al., 2015) . The average of two trials of each muscle was recorded and the sum of the right and left flexors, extensors and abductors were analyzed as the summed strength in pounds for each individual.
A C C E P T E D M
A N U S C R I P T 7 2.1.2 Ambulation Measures: All walking measures were collected in random order across participants, and participants were permitted to rest between tests for as long as they preferred to minimize fatigue. Participants who utilized assistive devices were asked to perform each test with the least-restrictive device. Both laboratory (walk velocity) and clinical measures of walking were assessed to examine walking speed and walking function.
Walk Velocity:
All participants were instructed to ambulate at their fastest, safe speed across the Zeno Walkway (Protokinetics, Havertown, PA), a 20-foot walkway that records footfalls in real-time. Participants completed six passes across the mat, and the average walk velocity for each person was calculated using a custom MATLAB program (The MathWorks, Inc., Natick, MA).
Timed Up and Go (TUG):
Participants were instructed to rise from a chair, walk three meters, turn and return to a sitting position in the chair as quickly as possible without running.
Participants performed two trials, with the first serving as a practice trial, and the time of second recorded as the final score. The TUG (Podsiadlo et al., 1991) incorporates functional tasks of turning and transitioning from sitting to standing into walking. In individuals with MS, the TUG is both valid (Cattaneo et al., 2006) and clinically relevant (Nilsagard et al., 2007) .
Timed 25 Foot Walk (T25FW):
Participants were instructed to walk at their quickest, safe speed along a flat twenty-five foot walkway (Rudick et al., 1997) . The average time of two trials was used as the final score. The T25FW has established reliability (Rosti-Otajavi et al., 2008) and validity (Kieseier et al., 2012) and is commonly used in MS clinical trials (Polman et al., 2010) .
Two-Minute Walk Test (2MWT):
To examine walking endurance, participants were instructed to cover as much distance as possible while walking for two minutes. The 2MWT is strongly correlated with the first two minutes of the Six-Minute Walk Test, (Gijbels et al., 2011) and is a feasible alternative to the Six-Minute Walk Test, (Gijbels et al., 2011) which has established reproducibility and reliability (Goldman et al., 2008) .
Magnetic Resonance Imaging
All MRI scans of the brain were collected on the same 3-Tesla Intera scanner (Philips Medical Systems, Best, The Netherlands). A full description of our scanning protocol can be found elsewhere (Reich et al., 2006; Reich et al., 2007; Reich et al., 2010) . Briefly, we collected artifact compared to other segments, and was therefore chosen for analyses.
Tract Reconstruction
We used the Fiber Association by Continuous Tracking method (Mori et al., 1999) in DTIStudio (Jiang et al., 2006) to reconstruct the whole-brain CST bilaterally following the manual ROI selection methods of Reich et al. 2006 . This method has excellent interrater reliability at κ>0.8 (Wakana et al., 2007) . After tract reconstruction, we normalized the data by interpolating to seven landmarks identifiable in every brain on axial sections from the DTI color maps following the methods of Reich et al., 2007 . FA and MTR were calculated with a custom MATLAB program (The MathWorks; Natick MA). An average of the left and right tracts was used for both the FA and MTR values.
Statistical Analyses:
All statistical analyses were performed with Stata version 11.1 (StataCorp). The Skewness and Kurtosis test was used to assess normality of the data distribution. Outliers were determined for each condition using box-and-whisker plots. Mann-Whitney tests were used to compare individuals with MS to controls. These groups are known to be different; thus corrections for multiple comparisons were not performed following the methods of Spain et al., 2012 , as these corrections would exaggerate the type II error. To understand the relationship of functional measures to structural MRI, the MS and control groups were combined and Spearman correlation coefficients were utilized to assess associations among quantitative measures of walking and strength and tract-specific imaging. These measures were corrected for multiple comparisons with an adjusted p-value of <0.007 indicating significance.
To understand what quantitative clinical and demographic measures best explain underlying microstructural integrity of the corticospinal tract, we used backward stepwise regression with Akaike Information Criterion (AIC) (Akaike, 1974) . AIC accounts for the number of predictors used and allows for comparison of models with different numbers of variables to assess model goodness of fit. This novel analysis in which the MRI measures serve as the dependent variables was designed to target the utility of the tools already in clinical use.
Results
Thirty To understand what quantitative clinical and demographic measures best explain underlying microstructural integrity of the corticospinal tract, we investigated the MRI factors with the strongest correlations to walking (i.e., MTR, FA, SCA) with regression modeling (Figures 3-5) . We show the results of three models designed to determine the unique contribution of (1) basic clinical information (age, gender, symptom duration and EDSS), (2) strength and walking (walk velocity, TUG, T25FW, 2MWT and summed strength), and (3) the combination of basic clinical information, strength and walking to each of the three MRI measures (FA, MTR and SCA).
Contribution of Basic Clinical Measures to Brain CST and SCA MRI measures.
Using CST MTR as the dependent variable, the final model includes age resulting in an adjusted Given the heterogeneous nature of the disease differences among individuals with MS and healthy controls are not unexpected. Studies examining CST-specific measures have shown no difference in FA between controls and individuals with RRMS (Daams et al., 2015; Reich et al., 2007) . One study demonstrated significant differences in CST MTR between individuals with MS and controls; however, the inclusion of progressive patients (i.e, greater disability) may have
Discussion
affected their results (Reich et al., 2007) . By and large, controls have not been included in studies examining relationships between CST DTI measures and walking (Hubbard et al., 2016; Klineova et al., 2016; Naismith et al., 2013; Tovar-Moll et al., 2015) . Overall, our CST FA and MTR values are in agreement with prior work (Reich et al., 2006; Reich et al., 2007; Reich et al., 2008) , and we highlight here the results of our regression modeling showing that functional outcome measures explain some of the variance in the microstructural integrity of the CST.
The search for quantitative outcomes has led to the use of both spinal cord and brain MRI measures to provide information about overall disability. Our results confirm the finding that SCA is correlated with EDSS (Bernitsas et al., 2015; Daams et al., 2015) , FSS Pyramidal (Daams et al., 2015) , and T25FW (Daams et al., 2015) , Although MRI is sensitive to changes associated with MS pathology (Agosta et al., 2006; Sämann et al., 2012; Filippi et al., 2013; DeStafano et al., 2014) , sequences are used in combination, as no single technique is specific enough to serve alone as a diagnostic tool. For example, MRI sequences such as T1 and MPRAGE of the brain and spinal cord are used to monitor medical progression of MS through structural changes, such as atrophy. While conventional MRI scans can detect the evolution of MS lesions, these techniques are not able to capture subtle changes in tract-related pathology and are poorly related to the clinical status of individual patients (Miller et al., 1998) . This study shows that MTR is a relevant and unique method that shows strong relationships to quantitative measures of walking. MT imaging has been found to be highly reproducible (Vavasour et al., 2006; Tjoa et al., 2008) , and data from our group has reported the utility of MT to detect differences between individuals with MS and healthy controls and between MS disease subtypes (Oh et al., 2013a; Oh et al., 2013b) . This imaging technique may provide insight into motor function that is commonly missed with conventional imaging. MT imaging in combination with conventional imaging may improve our understanding of the role of MRI as a surrogate marker for MS progression.
Outcome measurement selection for clinical trials has been notoriously challenging (Bermel et al., 2014) . indeed an annualized rate of change in CST MTR has been established (Harrison et al., 2011), suggesting that tract-specific MRI measures of the CST may add information about disease progression if quantitative measures of function were also assessed at these time points.
Limitations
There are several limitations in this study. The sample size was small, and there was no correction for lesions within the tracts. However, we did not experience any issues with tracking the CST in any of our participants, suggesting that tracking took into account any lesions present in the tract. Furthermore, chronic black hole lesion volume within the CST has been shown to be strongly correlated with not only FSS Pyramidal and T25FW, but also total EDSS and FSS Sensory (Tovar-Moll et al., 2015) , suggesting that it is a non-specific marker of disability, rather than specific to motor disability. Finally, accounting for lesions within the CST has yielded disparate results with some finding of relationships to EDSS (Tovar-Moll et al., 2015) while others do not (Daams et al., 2015) , perhaps due to large intra-and inter-observer variability in manual lesion segmentation (Jain et al., 2015) . For the spinal cord tracking we incorporated the entire axial area to calculate FA and MTR, as in Oh et al., 2013a, b;  this may have contributed to our findings. Hand-held dynamometry was used for strength assessment, which can be variable between testers. To limit this variability, all testers were trained by one experienced tester (KMZ) using a standardized technique. The reliability of hand-held dynamometry for hip strength measurement has been established by our group (Newsome et al., 2011) . In addition to quantitative strength and walking measures, there are other factors that may contribute to CST pathology that were not evaluated in this study.  Walking and strength were significantly related to CST MRI measures  Walk speed is a significant contributor to CST MRI measures on regression modeling  Walk speed and strength explain more variance in MRI measures than the basic exam  Adding walking and strength to the basic exam may improve disease monitoring
